We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This page includes summaries of the winning bids for the Digital Connectivity Infrastructure Accelerator (DCIA) pilots competition
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Advice and guidance on the health needs of migrant patients from Ukraine for healthcare practitioners.
Using an ecological momentary assessment to evaluate your digital health product.
Legal standards for labelling and composition of food products such as bottled water, milk and meat.
Information about subject knowledge enhancement (SKE) support for initial teacher training (ITT) recruitment.
The Fund aims to create the opportunity to build strong partnerships between UK and Turkish scientists, researchers and institutions.
Description of UKHSA adult surveillance programmes for COVID-19.
Following MHRA approval of a clinical trial, early breast cancer patients on endocrine-based therapy can benefit from a study with camizestrant.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
This playbook explains how we use social media at GDS. In it, we share our best practice, what we've learned and what we're planning to do.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
The review of the safety of isotretinoin has concluded.
Information for patients, healthcare professionals and developers of new medicines
Find out how venture capital schemes work, who can apply and what tax reliefs are available for your investors.
Explains testing from 1 April 2024 onwards and sets out the purpose of ongoing testing, who will be eligible to access testing and when tests should be used.
How to register your medical devices with the Medicines and Healthcare products Regulatory Agency (MHRA) for the markets in Great Britain and Northern Ireland
When tests to detect COVID-19 are commonly used (use cases) and what to consider when deciding which type of test to employ.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.